Related Experiment Videos
Bioinformatics platform development: from gene to lead compound
Alexis S Ivanov1, Alexander V Veselovsky, Alexander V Dubanov
1Institute of Biomedical Chemistry, RAMS, Moscow, Russia.
Methods in Molecular Biology (Clifton, N.J.)
|May 5, 2006
Summary
Bioinformatics advances enable rapid protein function prediction and drug target identification. The "from gene to lead" platform integrates computational and experimental methods for accelerated drug discovery.
Area of Science:
- Bioinformatics
- Genomics
- Drug Discovery
Background:
- The last decade has seen extensive genome mapping, driving the development of bioinformatics and experimental techniques.
- These advancements aim to predict protein functions and metabolic roles for novel drug targets.
Purpose of the Study:
- To describe the strategies of the "from gene to lead" platform.
- To detail the integration of computational and experimental approaches in drug discovery.
Main Methods:
- Genome mapping and analysis
- Bioinformatics tools for protein function prediction
- Experimental validation of drug targets
- Rational drug design principles
- Computer-aided drug discovery (CADD)
Main Results:
- The "from gene to lead" platform merges gene discovery with lead compound identification.
- Integration of virtual and experimental methods accelerates the drug discovery pipeline.
- Prioritization of novel drug targets is a key application.
Conclusions:
- The "from gene to lead" platform offers a comprehensive strategy for modern drug discovery.
- Interdisciplinary approaches combining bioinformatics and experimental methods are crucial for success.